Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites.

Nature | 2011

p53-binding protein 1 (53BP1) is known to be an important mediator of the DNA damage response, with dimethylation of histone H4 lysine 20 (H4K20me2) critical to the recruitment of 53BP1 to double-strand breaks (DSBs). However, it is not clear how 53BP1 is specifically targeted to the sites of DNA damage, as the overall level of H4K20me2 does not seem to increase following DNA damage. It has been proposed that DNA breaks may cause exposure of methylated H4K20 previously buried within the chromosome; however, experimental evidence for such a model is lacking. Here we found that H4K20 methylation actually increases locally upon the induction of DSBs and that methylation of H4K20 at DSBs is mediated by the histone methyltransferase MMSET (also known as NSD2 or WHSC1) in mammals. Downregulation of MMSET significantly decreases H4K20 methylation at DSBs and the subsequent accumulation of 53BP1. Furthermore, we found that the recruitment of MMSET to DSBs requires the γH2AX-MDC1 pathway; specifically, the interaction between the MDC1 BRCT domain and phosphorylated Ser 102 of MMSET. Thus, we propose that a pathway involving γH2AX-MDC1-MMSET regulates the induction of H4K20 methylation on histones around DSBs, which, in turn, facilitates 53BP1 recruitment.

Pubmed ID: 21293379 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA151329-01
  • Agency: NCI NIH HHS, United States
    Id: R01 CA136671
  • Agency: NCI NIH HHS, United States
    Id: R01 CA130996
  • Agency: NIA NIH HHS, United States
    Id: R56 AG020686-06A1
  • Agency: NIA NIH HHS, United States
    Id: R56 AG020686
  • Agency: NCI NIH HHS, United States
    Id: R01 CA136671-03
  • Agency: NCI NIH HHS, United States
    Id: R01 CA133966-03
  • Agency: NCI NIH HHS, United States
    Id: R01 CA133966
  • Agency: NCI NIH HHS, United States
    Id: CA151329
  • Agency: NCI NIH HHS, United States
    Id: CA130996
  • Agency: NCI NIH HHS, United States
    Id: R01 CA151329
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020686-06A2
  • Agency: NCI NIH HHS, United States
    Id: R01 CA133966-01A2
  • Agency: NCI NIH HHS, United States
    Id: R01 CA136671-02
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020686-07
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020686
  • Agency: NCI NIH HHS, United States
    Id: R01 CA130996-03
  • Agency: NCI NIH HHS, United States
    Id: R01 CA133966-02

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


MDA-MB-231 (tool)

RRID:CVCL_0062

Cell line MDA-MB-231 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions